Quick Answer
Chronic hepatitis B is treated with antiviral drugs such as tenofovir, entecavir, and peginterferon alfa-2a. These medications suppress the virus, reduce liver damage, and lower the risk of cirrhosis and liver cancer, but they rarely cure the infection. Treatment is long-term, often lifelong, and requires regular monitoring.
- Tenofovir and entecavir are first-line oral antivirals for chronic hepatitis B.
- Peginterferon alfa-2a is an injectable that may be used for a finite course.
- Treatment aims to suppress viral replication, not to eliminate the virus completely.
- Liver function and viral load are checked every 6-12 months during therapy.
- If one drug fails, switching to another antiviral is a common strategy.
- Hepatitis C is a different virus and is treated with direct-acting antivirals, not these drugs.
The Landscape
Hepatitis B is a viral infection that attacks the liver and can become chronic, meaning it lasts more than six months. Unlike hepatitis A, which is spread through contaminated food and water, hepatitis B spreads through blood and sexual contact. Chronic hepatitis B does not have a cure for most people, but antiviral medications can control the virus, preventing serious liver damage. The goal of treatment is to keep the virus at undetectable levels, reduce inflammation, and stop the progression to cirrhosis or liver cancer. Understanding the difference between hepatitis B and C is key, as they have different treatments and outcomes.
Treatment Windows by Infection
Bacterial infections clear with antibiotics measured in days: a single 500 mg intramuscular ceftriaxone dose for gonorrhea (doxycycline is added only if chlamydia has not been ruled out), seven days of doxycycline for chlamydia, penicillin injections for syphilis staged by duration. Viral infections play a longer game โ suppressive antivirals for herpes, daily ART driving HIV to undetectable, and 8โ12-week antiviral courses curing over 95% of hepatitis C cases.
Frequently Asked Questions
Which drug is used to treat chronic hepatitis b?
Chronic hepatitis B is treated with antiviral drugs such as tenofovir, entecavir, and peginterferon alfa-2a. These medications suppress the virus, reduce liver damage, and lower the risk of cirrhosis and liver cancer, but they rarely cure the infection. Treatment is long-term, often lifelong, and requires regular monitoring.
What medication is used to treat hepatitis c?
Chronic hepatitis B is treated with antiviral drugs such as tenofovir, entecavir, and peginterferon alfa-2a. These medications suppress the virus, reduce liver damage, and lower the risk of cirrhosis and liver cancer, but they rarely cure the infection. Treatment is long-term, often lifelong, and requires regular monitoring.
Is interferon used to treat hepatitis c?
Chronic hepatitis B is treated with antiviral drugs such as tenofovir, entecavir, and peginterferon alfa-2a. These medications suppress the virus, reduce liver damage, and lower the risk of cirrhosis and liver cancer, but they rarely cure the infection. Treatment is long-term, often lifelong, and requires regular monitoring.
What drug is used to treat chronic hepatitis b?
Chronic hepatitis B is treated with antiviral drugs such as tenofovir, entecavir, and peginterferon alfa-2a. These medications suppress the virus, reduce liver damage, and lower the risk of cirrhosis and liver cancer, but they rarely cure the infection. Treatment is long-term, often lifelong, and requires regular monitoring.
What drug is used to treat hepatitis b?
Chronic hepatitis B is treated with antiviral drugs such as tenofovir, entecavir, and peginterferon alfa-2a. These medications suppress the virus, reduce liver damage, and lower the risk of cirrhosis and liver cancer, but they rarely cure the infection. Treatment is long-term, often lifelong, and requires regular monitoring.
What drugs are used to treat hepatitis b?
Chronic hepatitis B is treated with antiviral drugs such as tenofovir, entecavir, and peginterferon alfa-2a. These medications suppress the virus, reduce liver damage, and lower the risk of cirrhosis and liver cancer, but they rarely cure the infection. Treatment is long-term, often lifelong, and requires regular monitoring.
Related Questions
Sources & Further Reading
- CDC โ Sexually Transmitted Infections
- CDC STI Treatment Guidelines
- WHO โ Sexually transmitted infections fact sheet
- MedlinePlus โ Sexually Transmitted Diseases
Figures reflect CDC surveillance and WHO estimates; they are population statistics, not personal risk predictions.